The increasing demand for residual host cell DNA testing, rapid adoption of the digital PCR testing market, and expansion of biologics testing services are transforming quality assurance processes within the biopharmaceutical industry. As the production of biologics, vaccines, gene therapies, and advanced therapeutic products continues to expand, ensuring product safety and...